Teva Launches First Inhalable Antipsychotic Drug in U.S.

Adasuve reduces agitation in adults with schizophrenia or bipolar I disorder.

Teva Pharmaceutical Industries is launching the first orally inhaled medicine for treating agitation associated with adult schizophrenia or bipolar I disorder in the United States, the company announced on Monday.

Adasuve is administered with an innovative handheld aerosol device developed by Alexza Pharmaceuticals. Previous treatment options for the condition were limited to pills or injections, sometimes requiring the use of restraints.

Teva acquired the rights to the drug, the first of the new therapeutic entities that are a major part of the company’s growth strategy, last May for $40 million up-front and $195 million in milestone payments.

As many as five million patients with bipolar I disorder or schizophrenia in the U.S. experience and seek treatment for agitation episodes.

The drug's efficacy was demonstrated in two clinical trials on acute agitation, one associated with schizophrenia and the other with bipolar I disorder. Adasuve showed significant reduction in agitation at two hours, with an effect seen as early as ten minutes post-dose.

"The availability of orally inhaled Adasuve provides a rapid onset of action that quickly improves symptoms for patients and gives providers in enrolled hospitals another treatment choice," said Michael McHugh, vice president and general manager, Teva Select Brands and Teva Women's Health.

McHugh said the drug's launch was part of the company's "ongoing commitment to enhancing patient care and bringing new therapies and delivery systems to the market that fit within our areas of expertise."

Teva's headquarters in Jerusalem.Credit: Bloomberg

Click the alert icon to follow topics:



Automatic approval of subscriber comments.

Subscribe today and save 40%

Already signed up? LOG IN


Crowds at Israel's Ben-Gurion International Airport, in April.

U.S. Official: West Bank Entry for Palestinian Americans Unrelated to Israeli Visa Waivers

Haaretz spoke with several people who said they had fled Ukraine, arrived in Israel,  and were asked to undergo DNA tests in order to establish paternity.

'My Jewish Grandmother Has a Number on Her Arm, Why Does Israel Greet Me This Way?'

FILE PHOTO: A Star of David hangs from a fence outside the dormant landmark Tree of Life synagogue in Pittsburgh's Squirrel Hill neighborhood in 2021.

American Judaism Is in Decline. That's Great News for American Jews

People taking part in the annual "March of the Living" to commemorate the Holocaust, between the former death camps of Auschwitz and Birkenau in Oswiecim, Poland, four years ago.

It’s Not Just the Holocaust. Israel Is Failing to Teach the History of the Jews

 A Jewish cemetery in Warsaw, Poland.

Israel and Poland Fight Over History, Truth - and Israeli Students

A collage of the Bentwich family throughout the generations.

Unique Burial Plot in Jerusalem Tells Story of Extraordinary Jewish Dynasty